Antithrombin III human

Antithrombin III human
Trade Name Antithrombin Iii Human
Orphan Indication Preventing or arresting episodes of thrombosis in patients with congenital AT-III deficiency and/or to prevent the occurrence of thrombosis in patients with AT-III deficiency who have undergone trauma or who are about to undergo surgery or parturition
USA Market Approval USA
USA Designation Date 1986-01-02 00:00:00
Sponsor American National Red Cross;9312 Old Georgetown Road;Bethesda, Maryland, 20814